-- 加拿大皇家銀行資本市場（RBC Capital Markets）在周五發布的一份報告中首次對Golub Capital BDC (GBDC)進行評級，報告指出，預計該公司未來一年的總回報率約為22%，其中股息收益率將起到關鍵推動作用。 RBC分析師表示，Golub專注於直接貸款領域的核心中端市場細分，與同業相比，該細分市場具有相對差異化優勢，因此是一個「極具吸引力的投資機會」。他們指出，與大型企業相比，在中端市場細分領域更容易獲得契約條款和有利條件。 分析師表示，自2009年以來，Golub的平均已實現虧損低於大多數同類商業發展公司，自成立以來淨收益約為6個基點。他們也指出，Golub的虧損波動性較小。 RBC分析師預測，該公司2026財年調整後淨投資收益為每股1.42美元，2027財年為每股1.33美元。 RBC首次對該公司股票進行評級，評級為“跑贏大盤”，目標價為15美元。
Price: $13.60, Change: $+0.31, Percent Change: +2.29%
Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.
SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.
Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.